Opiant Pharmaceuticals, Inc.
OPNTDelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385508
Opiant Pharmaceuticals, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 37 institutions reported holding it in 13F filings for Q4 2022, worth $43.2M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Opiant Pharmaceuticals, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 41 | 33 | −8 |
| Shares | 1.56M | 1.86M | +307.1K (+19.7%) |
| Value | $33.3M | $22.3M | −$11.0M (−33.0%) |
New holders (3)
Institutions that held Opiant Pharmaceuticals, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Stonepine Capital Management, LLC | 152,278 | $1.83M | 0.85% |
| Bank of New York Mellon Corp | 17,679 | $212.0K | 0.00% |
| CoreCap Advisors, LLC | 266 | $3.00K | 0.00% |
Sold out (11)
Institutions that held Opiant Pharmaceuticals, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Ovata Capital Management Ltd | 117,865 | $2.52M |
| DLD Asset Management, LP | 20,000 | $428.0K |
| SG3 Management, LLC | 16,084 | $345.0K |
| Bailard, Inc. | 15,042 | $322.0K |
| Marshall Wace, LLP | 13,584 | $291.0K |
| Mariner, LLC | 13,550 | $290.0K |
| Millennium Management LLC | 11,577 | $248.0K |
| Bridgeway Capital Management, LLC | 10,100 | $216.0K |
| JPMorgan Chase & Co | 7,466 | $160.0K |
| Newbridge Financial Services Group, Inc. | 2,050 | $44.0K |
| Sage Private Wealth Group, LLC | 5 | $0 |